Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus
- PMID: 26327768
- PMCID: PMC4548121
- DOI: 10.3748/wjg.v21.i32.9607
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus
Abstract
Aim: To compare and analyze the effects of obesity and non-alcoholic fatty liver disease (NAFLD) on the incidence of type 2 diabetes mellitus (T2DM) in Chinese subjects.
Methods: In 2008, a population of 4847 subjects was randomly sampled from 17 medical units for enrollment in this cohort study. Baseline information was obtained via a questionnaire on general information, physical examination (height, weight, and blood pressure), laboratory tests (triglycerides, total cholesterol, fasting blood glucose, alanine aminotransferase (ALT), uric acid, and creatinine), B-mode ultrasound, and ECG screening. The incidence of T2DM after four years of follow-up was calculated. Numeric variable data was tested for normality, with the data expressed as mean ± SD. Kaplan-Meier analysis was performed to calculate the cumulative incidence. The Cox proportional hazards model was used to analyze the relative risk (RR) of different body mass index (BMI) levels and NAFLD on T2DM, as well as analyzing the RR adjusted for age, sex, blood pressure, lipids, transaminases, uric acid, and creatinine.
Results: A total of 4736 (97.71%) subjects completed 4-year follow-up, with a median follow-up time of 3.85 years, totaling 17223 person-years. 380 subjects were diagnosed with T2DM, with a cumulative incidence of 8.0%. The cumulative incidence of T2DM in the NAFLD and control groups was 17.4% vs 4.1% (P < 0.001), respectively, while the incidence in overweight and obese subjects was 11.0% vs 15.8% (P < 0.001), respectively. The incidence of T2DM increased with an increase in baseline BMI. Cox regression analysis showed that the risk of T2DM in the NAFLD group (RR = 4.492, 95%CI: 3.640-5.542) after adjustment for age, sex, blood pressure, lipids, ALT, uric acid, and creatinine was 3.367 (2.367-4.266), while the value (RR, 95%CI) in overweight and obese subjects after adjustment for age, sex, BMI, blood pressure, lipids and other factors was 1.274 (0.997-1.629) and 1.554 (1.140-2.091), respectively. Stratification of three BMI levels (BMI < 24 kg/m(2), 24 kg/m(2) ≤ BMI < 28 kg/m(2), BMI ≥ 28 kg/m(2)) showed that the risk of T2DM in the NAFLD group was significantly higher than that in the control group (RR = 3.860, 4.049 and 3.823, respectively).
Conclusion: Compared with BMI, NAFLD could be better at forecasting the risk of T2DM in Chinese subjects, and may be a high risk factor for T2DM, independent of overweight/obesity.
Keywords: Cohort study; Incidence; Non-alcoholic fatty liver disease; Type 2 diabetes.
Similar articles
-
The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.Liver Int. 2016 Feb;36(2):275-83. doi: 10.1111/liv.12912. Epub 2015 Jul 30. Liver Int. 2016. PMID: 26176710
-
[Body mass index, waist circumference and waist-to-height ratio associated with the incidence of type 2 diabetes mellitus: a cohort study].Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Apr;50(4):328-33. doi: 10.3760/cma.j.issn.0253-9624.2016.04.009. Zhonghua Yu Fang Yi Xue Za Zhi. 2016. PMID: 27029364 Chinese.
-
[Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].Zhonghua Gan Zang Bing Za Zhi. 2021 Sep 20;29(9):867-872. doi: 10.3760/cma.j.cn501113-20200429-00223. Zhonghua Gan Zang Bing Za Zhi. 2021. PMID: 34638206 Chinese.
-
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103. World J Gastroenterol. 2015. PMID: 25892859 Free PMC article. Review.
-
Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis.Liver Int. 2019 Mar;39(3):557-567. doi: 10.1111/liv.13994. Epub 2018 Dec 4. Liver Int. 2019. PMID: 30358050
Cited by
-
Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease.Gut Liver. 2016 Sep 15;10(5):818-25. doi: 10.5009/gnl15331. Gut Liver. 2016. PMID: 27114415 Free PMC article.
-
Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus.Clin Interv Aging. 2016 Apr 18;11:445-52. doi: 10.2147/CIA.S104803. eCollection 2016. Clin Interv Aging. 2016. PMID: 27143868 Free PMC article.
-
The regulatory effects of fish oil and chitosan on hepatic lipogenic signals in high-fat diet-induced obese rats.J Food Drug Anal. 2017 Oct;25(4):919-930. doi: 10.1016/j.jfda.2016.11.015. Epub 2017 Feb 16. J Food Drug Anal. 2017. PMID: 28987369 Free PMC article.
-
Elevated fasting glucose level increases the risk of fatty liver disease: a 10-year study of 31,154 individuals.BMC Gastroenterol. 2022 Dec 16;22(1):521. doi: 10.1186/s12876-022-02615-0. BMC Gastroenterol. 2022. PMID: 36526962 Free PMC article.
-
Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease.Am J Physiol Endocrinol Metab. 2018 Nov 1;315(5):E795-E814. doi: 10.1152/ajpendo.00394.2017. Epub 2018 Mar 6. Am J Physiol Endocrinol Metab. 2018. PMID: 29509436 Free PMC article. Review.
References
-
- Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307:491–497. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical